In these previous studies on HER2-targeting affibody molecules, introduction of the (HE)3-tag caused a 5–10-fold reduction in hepatic uptake for indium-111 and technetium-99m labeled tracers, but had no effect on the tumor uptake [22,23]. This evidence concerns the gene ERBB2 and neoplasm.